CY2016033I2 - Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum - Google Patents

Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum

Info

Publication number
CY2016033I2
CY2016033I2 CY2016033C CY2016033C CY2016033I2 CY 2016033 I2 CY2016033 I2 CY 2016033I2 CY 2016033 C CY2016033 C CY 2016033C CY 2016033 C CY2016033 C CY 2016033C CY 2016033 I2 CY2016033 I2 CY 2016033I2
Authority
CY
Cyprus
Prior art keywords
infantum
genes encoding
antigenic determinants
chimeric genes
protein antigenic
Prior art date
Application number
CY2016033C
Other languages
English (en)
Other versions
CY2016033I1 (el
Original Assignee
Laboratorios Leti, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA2256124A external-priority patent/CA2256124C/en
Application filed by Laboratorios Leti, S.L. filed Critical Laboratorios Leti, S.L.
Publication of CY2016033I1 publication Critical patent/CY2016033I1/el
Publication of CY2016033I2 publication Critical patent/CY2016033I2/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CY2016033C 1998-12-23 2016-10-20 Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum CY2016033I2 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11382598P 1998-12-23 1998-12-23
CA2256124A CA2256124C (en) 1998-12-23 1998-12-23 Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, and protein encoded by said gene, and pharmaceutical composition useful for preventing and/or treating leishmaniosis in animals or humans
PCT/EP1999/010441 WO2000039298A1 (en) 1998-12-23 1999-12-23 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum

Publications (2)

Publication Number Publication Date
CY2016033I1 CY2016033I1 (el) 2017-03-15
CY2016033I2 true CY2016033I2 (el) 2017-03-15

Family

ID=25680668

Family Applications (3)

Application Number Title Priority Date Filing Date
CY20061101190T CY1105331T1 (el) 1998-12-23 2006-08-24 Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum
CY20091100739T CY1109221T1 (el) 1998-12-23 2009-07-14 Χιμαιρικο γονιδιο που κωδικοποιει τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum
CY2016033C CY2016033I2 (el) 1998-12-23 2016-10-20 Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CY20061101190T CY1105331T1 (el) 1998-12-23 2006-08-24 Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum
CY20091100739T CY1109221T1 (el) 1998-12-23 2009-07-14 Χιμαιρικο γονιδιο που κωδικοποιει τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum

Country Status (22)

Country Link
EP (1) EP1141305B1 (el)
CN (1) CN1158387C (el)
AT (2) ATE327332T1 (el)
AU (1) AU759316B2 (el)
BE (1) BE2016C049I2 (el)
BG (1) BG65569B1 (el)
BR (1) BRPI9916549B8 (el)
CY (3) CY1105331T1 (el)
CZ (1) CZ20012360A3 (el)
DE (2) DE69940793D1 (el)
DK (1) DK1141305T3 (el)
ES (2) ES2273519T3 (el)
HR (1) HRP20010554A2 (el)
HU (1) HUP0104743A3 (el)
IL (2) IL143956A0 (el)
LU (1) LU93259I2 (el)
MX (1) MXPA01006548A (el)
NL (1) NL300830I2 (el)
PT (2) PT1624063E (el)
SI (1) SI1624063T1 (el)
TR (1) TR200102655T2 (el)
WO (1) WO2000039298A1 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613337B1 (en) * 1997-02-12 2003-09-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
ES2169995B1 (es) * 2000-04-17 2003-12-01 Leti Lab Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno.
US6673351B1 (en) 2001-03-16 2004-01-06 Astralis, Llc Compositions and methods for the treatment and clinical remission of psoriasis
WO2006058243A2 (en) * 2004-11-24 2006-06-01 Yale University Leishmania antigens and related compositions and uses
WO2009090175A1 (en) * 2008-01-18 2009-07-23 Laboratorios Leti, S.L. Unipersonal Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant
RU2558233C2 (ru) * 2009-07-13 2015-07-27 Лабораториос Лети, С.Л. Диагностика паразитарного заболевания, такого как лейшманиоз, с использованием экстракта рибосомальных белков (rpe)
SA110310855B1 (ar) 2009-11-13 2014-09-16 Laboratories Leti S L Unipersonal استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي
BR102019003639A2 (pt) * 2019-02-22 2021-11-16 Fundação Oswaldo Cruz Proteína quimérica, seu método para produção e uso, bem como molécula de ácido nucleico, cassete de expressão, vetor de expressão, célula hospedeira, composição para diagnóstico de leishmaniose, kit de diagnóstico de leishmaniose e método de diagnóstico de leishmaniose in vitro
ES2795149B2 (es) 2020-06-08 2022-07-04 Univ Madrid Complutense Quimera sintetica multiepitopica como vacuna y tratamiento frente a leishmaniosis en mamiferos
CN112662694A (zh) * 2020-12-25 2021-04-16 康九生物科技(长春)有限公司 一种麦芽糖结合蛋白、麦芽糖结合蛋白表达载体、重组工程菌及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0703295A1 (en) * 1994-09-26 1996-03-27 Institut Pasteur Vaccine composition comprising recombinant BCG expressing gp 63 fusion protein
US5912166A (en) * 1995-04-21 1999-06-15 Corixa Corporation Compounds and methods for diagnosis of leishmaniasis
ES2133236B1 (es) * 1997-06-27 2000-04-16 Leti Lab Gen quimerico formado por las secuencias de dna que codifican los determinantes antigenicos de cuatro proteinas de l. infantum, aplicable para el diagnostico serologico de leishmaniosis canina y proteina obtenida.

Also Published As

Publication number Publication date
SI1624063T1 (sl) 2009-08-31
NL300830I2 (nl) 2020-08-31
CY1109221T1 (el) 2014-07-02
AU2434200A (en) 2000-07-31
CN1335889A (zh) 2002-02-13
IL143956A0 (en) 2002-04-21
EP1141305B1 (en) 2006-05-24
IL143956A (en) 2010-11-30
AU759316B2 (en) 2003-04-10
PT1624063E (pt) 2009-06-19
DE69931518D1 (de) 2006-06-29
BRPI9916549B8 (pt) 2022-08-30
DE69940793D1 (de) 2009-06-04
CY2016033I1 (el) 2017-03-15
TR200102655T2 (tr) 2002-04-22
BRPI9916549B1 (pt) 2018-10-02
BE2016C049I2 (el) 2019-03-05
ATE327332T1 (de) 2006-06-15
WO2000039298A1 (en) 2000-07-06
CN1158387C (zh) 2004-07-21
BG105725A (en) 2002-06-28
HUP0104743A2 (hu) 2002-03-28
DK1141305T3 (da) 2006-09-25
NL300830I1 (nl) 2016-09-28
ES2273519T3 (es) 2007-05-01
CZ20012360A3 (cs) 2001-10-17
ES2326174T3 (es) 2009-10-02
CY1105331T1 (el) 2010-03-03
ATE429498T1 (de) 2009-05-15
LU93259I2 (fr) 2016-12-06
MXPA01006548A (es) 2003-03-27
BG65569B1 (bg) 2008-12-30
PT1141305E (pt) 2006-10-31
EP1141305A1 (en) 2001-10-10
BR9916549A (pt) 2005-01-04
HRP20010554A2 (en) 2002-08-31
HUP0104743A3 (en) 2004-10-28
DE69931518T2 (de) 2006-12-21

Similar Documents

Publication Publication Date Title
CY2016033I1 (el) Χιμαιρικα γονιδια που κωδικοποιουν τους αντιγονικους καθοριστες τεσσαρων πρωτεϊνων του l. infantum
TR199902394A3 (tr) Elektrikli dis firçasi.
DE69936200D1 (de) Induktions heizgerät
NO20032745L (no) Et forbedret varmeapparat
DE69912211D1 (de) Heizvorrichtung
ES1039479Y (es) Piscina desmontable mejorada.
DE60141672D1 (de) Heizvorrichtung
DE60014639D1 (de) Riechstoffe
SI1141305T1 (sl) Himerni gen, ki kodira antigenske determinante stirih proteinov L. Infantum
DK0930804T3 (da) Varmekabel
ATA27298A (de) Heizgerät
EE00294U1 (et) Veesoojendi
ATA55598A (de) Wasserheizer
ATA50598A (de) Heizgerät
IT1304521B1 (it) Bigodino.
ATA17398A (de) Wasserheizer
ATA55498A (de) Wasserheizer
ES1044492Y (es) Parasol.
SE9803345D0 (sv) Kaffevärmare
FI982760A0 (fi) Lämpökone
ES1045945Y (es) Calefactor electrico.
NO985134D0 (no) Varmtvannsbereder
ATA49898A (de) Wasserheizer
NO980940D0 (no) Varmtvannsbereder
LV12193A (lv) Udens sildisanas iekarta